I've got quite a few pre-revenue shares. Including 4DS which is up 83% this week, apparently because for a picture of staff smiling at lunch
. Or maybe the period of time after testing commenced without bad news.
We look at BRN, currently with a market cap of only us$380m, look at the tech, the partners and TAM and just think where BRN will be in 5 years.
If you don't know anything about the tech then maybe you would consider it speculative. If you follow the experts (DYOR) BRN is a bargain.
Of course some of my pre-revenue stocks end up never-revenue basket cases. I find generally it is not worth selling the basket cases except for tax balancing. But then I'm a lapsed saints supporter, what the saints are 6th on the ladder.
(20min delay)